RDD_R&D Directors

R&D Directions, January/February 2012

Issue link: http://dc.cn.ubm-us.com/i/56250

Contents of this Issue

Navigation

Page 0 of 39

rddirections.com AN EXECUTIVE BRIEFING ON PHARMACEUTICAL RESEARCH AND DEVELOPMENT JANUARY/FEBRUARY 2012 Vol. 18, No.1 | $25 With 35 new drug approvals by FDA in 2011 and impending new approvals in 2012, pharmaceutical and biotech pipelines are showing some improvement, p.10 MOST NOTABLE PEOPLE: Nine people are acknowledged for their contributions to drug research and development in the 6th annual report, p.23

Articles in this issue

Links on this page

Archives of this issue

view archives of RDD_R&D Directors - R&D Directions, January/February 2012